Should I buy probiotics for depression?

The mode of use is the claim

The evidence changes depending on whether probiotics were added to medication or used by themselves. Combining those two uses into one average would hide the most important finding.

Added to an antidepressant: five trials found a moderate-to-large but imprecise average symptom benefit. The signal remained after removing the trial at highest risk of bias, although it became smaller.

Used alone: two small trials found no detectable benefit. That does not establish a definitive null, but it does not support stand-alone treatment.

Why this is not a gut-brain cure

The gut-brain axis offers a plausible story. The clinical trials do not prove that correcting the microbiome caused the improvement, and preliminary biological markers appeared only in some medicated add-on studies.

What the evidence actually supports is a probiotic added to antidepressant treatment in a small group of clinical trials, not a general theory that depression begins in the gut.

A shelf product does not inherit the result

The seven trials used different strains, doses, and formulations, mostly over about eight weeks. The evidence does not identify one winning product or show that a consumer probiotic matches what was tested.

The literature is small and partly funded by the probiotics industry. That does not erase the signal, but it lowers confidence and makes independent replication important.

What to expect

Short-term tolerability was generally reassuring, with no serious adverse events reported and mostly mild, temporary gastrointestinal effects. Long-term benefit, relapse prevention, and the best strain or dose remain uncertain.

Probiotics should not replace or delay antidepressants, psychotherapy, or other indicated care. Their current seat is a cautious add-on candidate for someone who understands that the evidence is early.